Company profile

bioMérieux designs, develops, produces, and sells systems used in clinical practice to diagnose infectious diseases (including HIV, tuberculosis, and respiratory infections), cancers, and cardiovascular pathologies based on a biological sample (blood, saliva, urine, etc.). Net sales break down by sector of application as follows:
  • medical applications (82.5%): in industry, microbiological testing of samples from finished products, materials during the manufacturing process, or the environment, primarily in the food-processing, pharmaceutical, and cosmetics sectors;
  • industrial applications (17.5%).
The group's diagnostic systems consist of three elements with related services: reagents, instruments (or platforms or analyzers), software, and services. Net sales are distributed geographically as follows: Europe/Middle East/Africa (35.9%), North America (39%), Asia/Pacific (19.2%) and Latin America (5.9%).

Source: Cofisem - Last Update: 04 Sep 2020
Key Executives
Chairman and Chief Executive Officer Alexandre Mérieux
Chief Financial Officer Guillaume Bouhours
Company Secretary Michel Baguenault
HR and Communication Director Valérie Leyldé
Investor Relations Director Sylvain Morgeau
Source: Cofisem - Last Update: 31 Mar 2020
Key figures
Millenium 2019 2018 2017 2016 2015
Net sales 2,674,800 2,421,300 2,288,200 2,103,200 1,964,600
Income from ordinary activities 2,674,800 2,421,300 2,288,200 2,103,200 1,964,600
Operating income 370,700 343,700 314,900 282,500 194,900
Cost of financial indebtedness net -20,600 -18,500 -16,200 -17,100 -24,700
Equity-accounted companies contribution to income 200 -400 -200 -300
Net profit from discontinued activities
Net income 269,700 255,500 237,500 179,200 110,300
Net income (Group share) 272,800 256,600 238,100 179,100 110,500
Fiscal year end 12.19 12.18 12.17 12.16 12.15
Length of fiscal year (month) 12 12 12 12 12
Currency & Unit EUR - thousands EUR - thousands EUR - thousands EUR - thousands EUR - thousands
Account Standards
Source: Cofisem - Last Update: 04 Sep 2020
Shareholder information
Institut Mérieux 58.90 %
GIMD 5.10 %
Groupe Industriel Marcel Dassault 4.60 %
Sofina SA 2.12 %
Employees 0.64 %
Treasury stock 0.05 %
Source: Cofisem - Last Update: 31 Mar 2020

Address

bioMérieux

376 Chemin de l'Orme
FR-69280 Marcy l'Etoile
France
Source: Cofisem - Last Update: 04 Sep 2020